Brought to you by 
Orthovita nets $32.2mm in equity offering; sells $45mm in debt
27 Aug 2007
Executive Summary
Orthovita (biomaterials and implants for spine and orthopedic applications) netted $32.2mm through a registered direct offering of 12.3mm common shares priced at $2.64 each (a 17% discount). Lead and new investor Essex Woodlands Health Ventures was joined by returning shareholders Lehman Brothers, Magnetar Capital, and affiliates of William Harris Investors. A member of Essex Woodlands will take a seat on the company's board. Orthovita also agree to sell $45mm in 10% five-year senior secured notes to Lehman affiliate LB I Group. The company also issued LB I five-year warrants to buy 1.47mm common shares exercisable at $3.41. Concurrently, Orthovita terminated its revenue interest obligation with Paul Capital.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
Deal Status
- Final
Deal Type
-
Financing
- Nonconvertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Orthovita nets $32.2mm in equity offering; sells $45mm in debt
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice